Abstract
Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/rheumatology/keac273
Copy DOIJournal: Rheumatology (Oxford, England) | Publication Date: May 17, 2022 |
Citations: 13 |
Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3.
Join us for a 30 min session where you can share your feedback and ask us any queries you have